Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients With Localized Prostate Cancer: a Prospective, Single-Arm, Pivotal Clinical Study
A prospective, multi-centre, single-arm study, planned in 110 patients. The primary
objective of the study is to further evaluate the safety and efficacy of a magnetic
resonance imaging (MRI)-guided transurethral ultrasound therapy system (TULSA-PRO) intended
to ablate prostate tissue of patients with localized, organ-confined prostate cancer.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society